Prince Pharmaceutical Co., Ltd. (6935.TWO)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Da Li | GM & Chairman | -- | -- | -- |
Cuiwei Chen | Accounting Supervisor | -- | -- | -- |
Prince Pharmaceutical Co., Ltd.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 210
Description
Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. It supplies its products to Spain and Europe. Prince Pharmaceutical Co., Ltd. was founded in 1962 and is headquartered in Yunlin County, Taiwan.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 21, 2024 at 12:00 AM UTC
Ex-Dividend Date